Rifampicin Prescription Medicines in the Philippines

FIXCOM 2 Rifampicin / Isoniazid 150 / 75 is used for the management of all forms of tuberculosis, including both pulmonary and extrapulmonary infections. This product is generally indicated for use during the continuation phase of short-course treatment regimens. Its components, Rifampicin and Isoniazid, work together to kill or prevent the growth of the bacteria responsible for the disease. This fixed-dose combination simplifies the treatment regimen for patients.

Indications/Uses Treatment of both pulmonary and extrapulmonary tuberculosis in the intensive initial phase of treatment.   Dosage/Direction for Use Adults:  3 tablets/day for an average body weight of 50 kg. Patients weighing >70 kg:  5...

IFAMSO Rifampicin / Isoniazid 150 / 75 is used for the management of all forms of tuberculosis, including both pulmonary and extrapulmonary infections. This product is generally indicated for use during the continuation phase of short-course treatment regimens. Its components, Rifampicin and Isoniazid, work together to kill or prevent the growth of the bacteria responsible for the disease. This fixed-dose combination simplifies the treatment regimen for patients.

FLAMAWAY-2 Rifampicin / Isoniazid 150 / 75 is used for the management of all forms of tuberculosis, including both pulmonary and extrapulmonary infections. This product is generally indicated for use during the continuation phase of short-course treatment regimens. Its components, Rifampicin and Isoniazid, work together to kill or prevent the growth of the bacteria responsible for the disease. This fixed-dose combination simplifies the treatment regimen for patients.

Indications/Uses Fixcom 2:  For the treatment of pulmonary and extrapulmonary tuberculosis. Fixcom 3:  For the continuation phase of pulmonary and extrapulmonary tuberculosis. Fixcom 4:  For initial or intensive phase treatment of all forms of pulmonary and...

DUOMAX Rifampicin / Isoniazid 150 / 75 is used for the management of all forms of tuberculosis, including both pulmonary and extrapulmonary infections. This product is generally indicated for use during the continuation phase of short-course treatment regimens. Its components, Rifampicin and Isoniazid, work together to kill or prevent the growth of the bacteria responsible for the disease. This fixed-dose combination simplifies the treatment regimen for patients.